Efficacy and Safety of Generic Dasatinib as a Second-line Treatment for Patients with Chronic Myeloid Leukemia: a Multicenter Retrospective Study in Hubei Province, China
Crossref DOI link: https://doi.org/10.1007/s11596-018-1976-0
Published Online: 2018-12-07
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Li-feng
Yuan, Guo-lin
Zhong, Zhao-dong
Zou, Ping
Li, Deng-ju
Bao, Yin
Ren, Hong-bo
Meng, Li
Li, Wei-ming
Text and Data Mining valid from 2018-12-01
Article History
Received: 7 June 2018
Revised: 3 July 2018
First Online: 7 December 2018